World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 31 August 2015
Main ID:  NCT02533076
Date of registration: 14/07/2015
Prospective Registration: No
Primary sponsor: Universitaire Ziekenhuizen Leuven
Public title: The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients
Scientific title: The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients
Date of first enrolment: November 2014
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02533076
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science  
Phase:  Phase 0
Countries of recruitment
Belgium
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Only healthy controls: Subject is in good health, based on medical history and
physical examination

- White (Caucasian) male or female subjects, aged > or = 8 year.

- Subject is capable and willing to give informed consent.

Exclusion Criteria:

- Any abnormality of the skin which may interfere with the study assessments.

- Excessive hair growth on the volar surface of the forearm.

- Excessive tanning (any exposure to sunlight or a tanning bed which would cause a
sunburn reaction) throughout the study and incapable to cover the forearms for 24
hours prior to the study period.

- Subject using topical treatments on the forearm.

- History of sensitivity to the fruits of capsicum plants (e.g. chilli peppers).

- Any situation that can compromise the study, including a predictable lack of
cooperation from the volunteer.

- Female subject is pregnant or breastfeeding.



Age minimum: 8 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cystinosis
Intervention(s)
Device: Temperature sensitivity measurement with Advanced Thermal Stimulation
Other: Challenge agent: placebo
Other: Challenge agent: capsaicin
Device: Mechanical stimulation with Von Frey filaments
Primary Outcome(s)
Change from baseline of the dermal blood flow response to topical applied capsaicin at 10, 20, 30, 40, 50 and 60 minutes, measured with Laser Doppler Imaging and expressed in % change to baseline [Time Frame: Day 1 at baseline and 10, 20, 30, 40, 50 and 60 minutes after capsaicin application]
Secondary Outcome(s)
Change from baseline of the skin sensitivity response after topical applied capsaicin at 10, 20, 30, 40, 50 and 60 minutes, measured with the Numerical rating scale and skin sensitivity to mechanical stimulation, measured with Von Frey filaments. [Time Frame: Day 1 at baseline and 10, 20, 30, 40, 50 and 60 minutes after capsaicin application]
Temperature sensitivity (detection and pain threshold), measured with Advanced Thermal stimulation and expressed in degrees Celsius. [Time Frame: Day 1]
Secondary ID(s)
CCP13-3302-CYST
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history